ClavystBio is a life sciences investor and venture builder established by Temasek to accelerate the commercialization of breakthrough ideas into health impact. We invest and partner with founders and entrepreneurs to launch and grow global companies from Asia. Our focus spans therapeutics, digital health and medtech, with an emphasis on first-in-class science and technology. Our collaborative space, Node 1, provides plug-and-play spaces for ventures that have graduated from incubators to progress to their next milestones. By bringing start-ups together, we foster a vibrant and supportive community.
| Website | https://www.clavystbio.com/ |
| Employees | 22 (22 on RocketReach) |
| Founded | 2022 |
| Industry | Investment Management |
| Keywords | Life Sciences Investment, Commercialization, Life Science Venture Capital, Venture Building, Biotechnology Venture Capital, Breakthrough Ideas, Medical Innovation, Healthcare Investment, Therapeutics Investment, Healthtech, Health Impact, Global Health, Pharmaceutical Investment, Seed Funding, Series A Funding, Entrepreneurs, Founders, Startups |
| Competitors | Tempus Labs, Inc., Exact Sciences, Guardant Health, GRAIL, Myriad Genetics, Foundation Medicine, Invitae, Ambry Genetics, Millennium Health, carisls +52 more (view full list) |
Looking for a particular ClavystBio employee's phone or email?
ClavystBio Questions
Khoo Shih is the CEO of ClavystBio.
22 people are employed at ClavystBio.
Top ClavystBio Employees
-
25+
-
23
-
23
-
Jason Ng
Legal Lead at ClavystBio
Singapore11
Related Companies
